Recently, Martinez-Valbuena and colleagues, using 138 subjects with neurodegenerative diseases or T2D, demonstrated increased immunoreactivity of IAPP, α-Syn, tau and prion protein in pancreatic cells of these subjects, as compared to controls. This evidence concerns the gene IAPP and type 2 diabetes mellitus.